Table 5.
Endogenous inhibitors | Angiostatin |
Endostatin | |
Thrombospondin-2 | |
Interleukin-4, interleukin-13 | |
Platelet factor-4/CXCL4 chemokine | |
Exogenous inhibitors | Classical disease-modifying antirheumatic drugs |
Anti-tumor necrosis factor biologics | |
Thalidomide | |
Fumagillin analogs | |
Vascular endothelial growth factor inhibitors | |
Hypoxia-inducible factor heterodimer inhibitors | |
Angiopoietin-1/Tie2 inhibitors | |
αVβ3 integrin inhibitors | |
Microtubule destabilizers (for example, paclitaxel) | |
Others (for example, glitazones) |